Fierce Biotech1 min read
saveBiogen inks $411M neurodegeneration pact with protein degrader biotech TrimTech
Cambridge, U.K.-based TrimTech Therapeutics has linked up with Biogen in a collaboration worth up to $411 million in biobucks to develop protein degraders for neurodegenerative diseases.
comments(0)
5-min edit window · permanent after that